Mr Greg C Boettcher, DO | |
267 N Canyon Dr, Gooding, ID 83330 | |
(208) 934-4446 | |
(208) 934-4442 |
Full Name | Mr Greg C Boettcher |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 24 Years |
Location | 267 N Canyon Dr, Gooding, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508899295 | NPI | - | NPPES |
S4117 | Other | BLUE CROSS | |
000010141448 | Other | ID | BLUE SHIELD |
805804000 | Medicaid | ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0237 (Idaho) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Canyon Medical Center | Gooding, ID | Hospital |
St Lukes Magic Valley Medical Center | Twin falls, ID | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Canyon Medical Center Inc | 0941371439 | 45 |
News Archive
Cambridge Heart, Inc., today reported results for the three and six months ended June 30, 2010. Full financial statements and corresponding commentary can be found in the Company's Form 10-Q, which is expected to be filed with the Securities and Exchange Commission on August 16, 2010.
The University of Illinois at Chicago and the Binaytara Foundation have partnered to develop Nepal's first blood and marrow transplant unit and to organize the country's first international conference on blood cancers.
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
At a town hall meeting in Abuja, Nigeria, on Wednesday, the fifth stop of her seven-nation African tour, Secretary of State Hillary Clinton urged Nigeria to fix its "flawed electoral system," and "pledg[ed] U.S. assistance in efforts to bring peace to the volatile and oil-rich Delta region," the Wall Street Journal reports.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
› Verified 7 days ago
Entity Name | North Canyon Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609046671 PECOS PAC ID: 0941371439 Enrollment ID: O20090409000304 |
News Archive
Cambridge Heart, Inc., today reported results for the three and six months ended June 30, 2010. Full financial statements and corresponding commentary can be found in the Company's Form 10-Q, which is expected to be filed with the Securities and Exchange Commission on August 16, 2010.
The University of Illinois at Chicago and the Binaytara Foundation have partnered to develop Nepal's first blood and marrow transplant unit and to organize the country's first international conference on blood cancers.
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
At a town hall meeting in Abuja, Nigeria, on Wednesday, the fifth stop of her seven-nation African tour, Secretary of State Hillary Clinton urged Nigeria to fix its "flawed electoral system," and "pledg[ed] U.S. assistance in efforts to bring peace to the volatile and oil-rich Delta region," the Wall Street Journal reports.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Greg C Boettcher, DO 267 N Canyon Dr, Gooding, ID 83330-5500 Ph: (208) 934-4446 | Mr Greg C Boettcher, DO 267 N Canyon Dr, Gooding, ID 83330 Ph: (208) 934-4446 |
News Archive
Cambridge Heart, Inc., today reported results for the three and six months ended June 30, 2010. Full financial statements and corresponding commentary can be found in the Company's Form 10-Q, which is expected to be filed with the Securities and Exchange Commission on August 16, 2010.
The University of Illinois at Chicago and the Binaytara Foundation have partnered to develop Nepal's first blood and marrow transplant unit and to organize the country's first international conference on blood cancers.
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
At a town hall meeting in Abuja, Nigeria, on Wednesday, the fifth stop of her seven-nation African tour, Secretary of State Hillary Clinton urged Nigeria to fix its "flawed electoral system," and "pledg[ed] U.S. assistance in efforts to bring peace to the volatile and oil-rich Delta region," the Wall Street Journal reports.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
› Verified 7 days ago
Reid Wayne Lofgran, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 267 N Canyon Dr, Gooding, ID 83330 Phone: 208-934-4433 Fax: 208-934-4442 | |
Jennifer Marie Olsen, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 267 N Canyon Dr, Gooding, ID 83330 Phone: 208-934-4446 Fax: 208-934-4442 | |
Mark D Spencer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Idaho Street, Gooding, ID 83330 Phone: 208-934-5900 Fax: 208-934-5719 | |
Fred P Miller, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 425 Idaho Street, Gooding, ID 83330 Phone: 208-934-5900 Fax: 208-934-5719 | |
Florian John Gies, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Idaho St, Gooding, ID 83330 Phone: 208-934-5900 Fax: 208-934-5719 | |
Cooper John Field, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 267 N Canyon Dr, Gooding, ID 83330 Phone: 208-934-4446 |